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Summary: 
 
WHAT IS KNOWN AND OBJECTIVES: Obstetrics services are a high-throughput and high-
risk environment poised for pharmacist involvement, but determining how to ideally allocate 
services is difficult. There is recent interest in the development of tools for service 
prioritisation, but none are specifically targeted to obstetrics. Therefore, the aim of this study 
was (1) to conduct a practice audit surveying the demographics of patients attending 
obstetrics wards at a high-capacity maternity hospital, and (2) to evaluate a triage tool 
developed to prioritise pharmacy services. 
METHODS: A retrospective case review of women discharged after birth admissions was 
undertaken at a hospital in National Health Service (NHS) Scotland during June 2014. 
Demographic and admission data were collected, as well as pharmacist interventions and 
missed opportunities in patient care on postnatal wards. A pharmacy triage tool was 
developed and retrospectively applied to each case to ascertain a risk category that would 
trigger and target pharmacist review. Interventions/opportunities were classified as either 
clinical (medication-related) or administrative (potential for error development). 
RESULTS AND DISCUSSION: 175 cases were reviewed with a median age of 29 years old. 
Eighty-six patients (49.1%) were retrospectively classified with elevated risk using the triage 
tool. A total of 117 charts (66.9%) were identified with missed opportunities for pharmacist 
intervention, which was significantly higher among patients classified as higher risk (75.6 vs. 
58.4%, p=0.017). Compared to low risk patients, patients with a higher risk classification had 
lower rates of administrative missed opportunities (55.4 vs. 80.8%, p=0.015), but numerically 
higher rates of clinical (26.2 vs. 9.6%, p=NS) and mixed clinical/administrative (18.5 vs. 
9.6%, p=NS) missed opportunities, although this failed to reach statistical significance.  
WHAT IS NEW AND CONCLUSION: Evaluation of a triage tool for obstetric services 
demonstrated potential for prioritising higher risk patients for pharmacist review and 
addressing opportunities for clinical improvements. 
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Main text: 
 
WHAT IS KNOWN AND OBJECTIVE: 
 
Pharmacists play an integral role in the hospital setting for ensuring the safe and optimal use 
of medications, as well as optimising medication therapy with the most efficient use of 
available resources. However, pharmacists themselves have become a limited resource in 
the face of increasing numbers of hospital admissions, changing patient demographics, and 
increased complexities of medication therapy regimens. In the absence of a clinical 
pharmacist ideally being involved in every hospital case, there is need to prioritise where 
services are most required. 
 
Tools for pharmacist service prioritisation have been developed for the general hospital 
population. A recent effort to identify high-risk patients was trialled in National Health Service 
(NHS) Ayrshire & Arran health board using medication-specific µIODJV¶LGHQWLILHGIURPWKH
electronic prescribing system, such as use of anticoagulants, or extended durations of 
antibiotic utilisation.1 Similarly, a group of pharmacists in New Zealand developed a fully 
integrated tool which expanded upon this concept and identified 38 clinical characteristics 
which contribute to calculating a priority risk score for a patient.2 The tools rely largely on 
events during admission to determine potential risk, such as high-risk medications removed 
from automated dispensing FDELQHWVDNDµ3\[LVPDFKLQHV¶WUDQVIHUVWRKLJKHUDFXLW\XQLWV
and extremes in laboratory values.1-2 These tools have found good support among 
pharmacists, and have resulted in notable service improvements such as reduction in time to 
pharmacist intervention and time savings in service workload.1-2  
 
Obstetric services have opportunity for pharmacist involvement due to the high-acuity 
environment, specialised knowledge required for use of medications during pregnancy and 
lactation, and potential risk associated with errors and adverse events.3 Despite a relatively 
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young patient population, an estimated 80% of women use at least one prescription 
medication during pregnancy.4 Obstetric admissions vary from uncomplicated spontaneous 
vaginal deliveries (SVD) in healthy women to more complex scenarios involving emergency 
or elective caesarean sections (EMCS/ELCS), drug dependency in mother and baby, and 
management of specialised co-morbidities such as gestational diabetes mellitus. Risks in 
pregnant women are unique compared to general medical admissions, and hospitalisations 
for obstetric services are often short, meaning the window for pharmacist review is small and 
adverse events may not be realised until after the patient is discharged. For these reasons, 
the use of established risk tools developed for the general medical population are not fully 
suitable.  
 
Due to the urgency associated with obstetrics admissions, predicting service needs and 
coverage is difficult; as such, triage tools have been the focus among medical, nursing and 
midwifery staff.5 Development of a triage protocol for pharmacists working in obstetrics is 
lacking, yet has the potential to not only aid patient care, but improve service planning. 
Accordingly, the aim of this study was (1) to conduct a practice audit surveying the 
demographics of patients attending maternity wards at a high-capacity obstetrics facility, and 
(2) to evaluate a triage tool developed to prioritise pharmacy services.  
 
METHODS: 
 
Practice setting 
The study was undertaken in an urban medical centre in Scotland with 100 beds allocated to 
maternity and neonatal services. The wards service approximately 6500 births each year 
and at the current time, have 2.2 full-time equivalent (FTE) pharmacists specialising in 
:RPHQDQG&KLOGUHQ¶V6HUYLFHVSURYLGLQJ clinical services for the neonatal unit from 0830-
1700 Monday-Friday, including public holidays; these pharmacists are additionally 
responsible for obstetrics services as staffing levels allow. An additional team of pharmacists 
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provide general coverage in the central pharmacy on an in and out-of-hours basis when 
specialist pharmacists are not available. Hospital services currently utilise a mixed 
paper/electronic charting system, with handwritten medication orders recorded in the paper 
PHGLFDWLRQDGPLQLVWUDWLRQUHFRUG0$5DNDµNDUGH[¶ Standardized pharmacist medication 
reconciliation at admission is not currently performed. Reconciliation at discharge is 
performed electronically using an immediate discharge letter (IDL) and is checked by a 
pharmacist where possible.   
 
Study design and sampling 
The present study was a retrospective chart review of patients during June 2014. Charts 
were randomly convenience sampled from two maternity wards and reviewed by a 
pharmacist during data collection; patients were included if their admission resulted in child 
birth (as opposed to other antenatal hospitalisations). Data collected included patient 
demographics (age, height, weight, allergies, gestation, gravida/parity) and admission 
characteristics (presentation [planned/spontaneous], length of stay [LOS], mode of delivery). 
Charts were assessed for evidence of pharmacist assessment or intervention at two time-
points: (1) during the stay, signified by physical annotation in the chart or MAR, or (2) at the 
time of discharge, signified by a pharmacist screening notation on the IDL. Records were 
assessed to identify common medication-related issues as discussed and identified by the 
investigator team prior to the start of the study, classified as either µclinical¶RUµadministrative¶ 
types. Clinical issues included those pertaining directly to medication therapy, such as 
identification of incorrect dosing schemes for standardized protocol medications used by the 
hospital, incorrect scheduling of the medication, lack of indication for a particular therapy, or 
need for pharmacokinetics. Primary areas of clinical assessment (common to all obstetric 
admissions) included analgesia regimen, antibiotic prophylaxis, venous thromboembolic 
(VTE) prophylaxis and need for iron supplementation; however, other clinical issues specific 
to patient cases were also recorded. Administrative issues included inconsistencies in 
charting and documentation, such as lack of notation of patient weight, allergies or 
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gravida/parity in the admission chart, or failing to use standardized hospital assessment 
forms, such as for determination of VTE risk and corresponding therapy. Administrative 
issues were included in the analysis as these may indicate areas with potential for 
downstream medication errors to develop based on procedural inefficiencies and omissions. 
Clinical and administrative issues were UHFRUGHGDVDQµLQWHUYHQWLRQ¶LIDGGUHVVHGE\D
SKDUPDFLVWGXULQJDGPLVVLRQRUDµPLVVHGRSSRUWXQLW\¶LIQRWDGGUHVVHG 
 
A pharmacy triage tool was developed to risk stratify patients admitted to the obstetrics 
service to help prioritise services (Figure 1). The tool was designed by an expert group of 
three clinical pharmacists delivering obstetric services, as well as informal input from several 
academic collaborators in the clinical area. Several rounds of revision and trial were used to 
balance the tool for incorporation of variables of interest and to be efficient within the realistic 
time constraints of clinical service. Upon completion of the triage tool, patients were 
assigned to one of two risk categories: (1) red ± need for obstetric pharmacist to review, or 
(2) green ± no need for specialist review unless requested by medical/nursing staff. Criteria 
for red classification were developed with input pharmacists from the service on common 
issues requiring prioritisation for potentially vulnerable patients, including demographic 
characteristics (young age, extreme weight, poor literacy), substance abuse/misuse, 
common medical co-morbidities and high-risk medication use. The triage tool was 
retrospectively applied to each patient case to ascertain what their risk category would have 
been upon triage, utilising referral letters and admission documentation. Not all medical co-
morbidities and medications were automatically deemed as qualifiers for red classification; 
determination of severity was made by a pharmacist reviewing the chart based whether the 
disease was uncontrolled or of changing status, if it required active medication for treatment, 
or if there was potential for adverse events with use or withdrawal. Characteristics were 
described as a function of the full cohort, and additionally split by risk category. Interventions 
were assessed by red/green risk category to compare rates of current service intervention 
during admission and discharge.  
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Statistical analysis 
Statistical analysis was performed using Minitab® 16 (Minitab Ltd., Coventry, UK) and SPSS 
Statistics 21 (IBM Corporation, Armonk, NY, USA). Continuous data were compared using a 
Mann-Whitney test, and categorical data were compared with a 2-proportion test with a 
Bonferroni correction applied to reduce the error associated with multiple comparisons. The 
project was considered a service evaluation by the West of Scotland Research Ethics 
Service and was exempt from ethics review. 
 
RESULTS AND DISCUSSION: 
 
A total of 175 patient charts were retrospectively reviewed, with demographic and 
admissions characteristics detailed in Table 1. Patients had a median age of 29 years old, 
and largely were on their 2nd pregnancy with a median gestation of 39 weeks and 2 days. 
The slight majority of patients had planned admissions, of which 34 patients (37.0% of 
cases) resulted in SVD; a total of 54 patients (65.1%) with spontaneous admissions resulted 
in an SVD (p<0.001 for difference). Median LOS was reduced slightly (2.5 vs. 3.0 days, 
p<0.001) among spontaneous admissions. Less than 10% of patients delivered by assisted 
methods (labelled as 'other'), including forceps, ventouse or breech deliveries. Some 
demographic data were unavailable (<3% patients) due to lack of notation in the chart.  
 
A total of 86 patients (49.1%) were retrospectively classified as KLJKHUULVNµred¶ using the 
triage criteria. The most common criteria for red classification was medical co-morbidity (57 
patients; 66.2% of group), followed by demographics (43 patients; 50.0% of group) and high-
risk medication use (33 patients; 38.4% of group); substance use/misuse made up a minority 
of red classifications with 6 patients (7.0% of group). A total of 45 patients (52.3% of group) 
were classified as red based on more than 1 criterion on the triage tool. Demographic and 
admission characteristics were statistically similar between red and green groups, with the 
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exception of body mass index (BMI), which was lower among patients with a green 
classification. Patients classified as red had lower rates of SVD (47.6 vs. 53.9%) and ELCS 
(17.9 vs. 21.4%) but a higher rate of EMCS (25.0 vs. 15.7%) compared to patients classified 
DVµJUHHQ¶DOWKRXJKQRQHRIWKHVHGLIIHUHQFHVUHDFKHGVWDWLVWLFDOVLJQLILFDQFH 
 
There was evidence of pharmacist intervention during admission and professional screening 
at discharge in approximately half of all charts reviewed (Table 2). Among charts with 
interventions, the majority (60.5%) were administrative while the remainder were clinical 
(20.9%) or mixed clinical/administrative (18.6%). Upon review, a total of 117 charts (66.9%) 
overall were identified with missed opportunities for intervention, with a similar split of 
problems identified. When retrospectively classified according to red/green risk, there were 
similar rates of pharmacist intervention during admission and professional screen. However, 
the rate of missed opportunities for intervention was significantly higher among red patients 
(75.6 vs. 58.4%, p=0.017). Compared to green, patients with a red classification had lower 
rates of administrative missed opportunities (55.4 vs. 80.8%, p=0.015), but numerically 
higher rates of clinical (26.2 vs. 9.6%, p=NS) and mixed clinical/administrative (18.5 vs. 
9.6%, p=NS) missed opportunities as well.  
 
The most common administrative issue identified during interventions (61/68; 89.7% of 
group) and missed opportunities (60/95; 63.2% of group) was a lack of patient weight 
recorded on the MAR. Charting discrepancies, such as different recorded weights, 
gravida/parities and allergies were noted in 19 instances of missed opportunities (20.0% of 
group). Common clinical issues addressed during admission included dose and regimen 
adjustments for analgesia (18/34; 52.9% of group) and VTE prophylaxis (6/34; 17.6% of 
group), while missed opportunities included several additional issues, relating to medication 
reconciliation (13/39; 33.3% of group), or incorrect assessment of VTE risk (8/39; 20.5% of 
group) and incorrect low-molecular weight heparin (LMWH) doses (9/39; 23.1% of group) 
based on institutional algorithms. 
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This retrospective ward audit described the characteristics of patients attending the 
maternity ward and evaluated the use of a simple tool to triage pharmacy services on the 
ward. Patients were retrospectively classified into two risk groups using the triage tool: red 
and green. Irrespective of classification, approximately 50% of patients received a screening 
by a pharmacist at discharge. The screening rate may relate to the time coverage (weekday, 
day-time hours) of specialist pharmacy services, or pressured pharmacist resources in 
comparison to patient care demands specifically within neonatal services. The health board 
UHSRUWHGWKDW:RPHQ	&KLOGUHQ¶V2EVWHWULFVDQG1HRQDWDOVHUYices in the hospital from the 
same month in the previous year totalled 2111 occupied bed days,6 equating to 32 beds/day 
coverage for each FTE pharmacist. Approximately 30% of this capacity is consumed by 
neonatal beds, which generally are of higher acuity and require a greater share of service 
time.  
 
The rate of any missed opportunities was increased 30% among µUHG¶patients; more 
importantly, the rate of clinical missed opportunities was nearly 3-fold higher. It is difficult 
from the nature of this study to quantify the measureable impact of pharmacist 
review/intervention and the eventual impact of these missed opportunities. This study did not 
IRFXVRQWUDGLWLRQDOµKDUG¶FOLQLFDORXWFRPHVVXFKDVGHDWKEXWUDWKHUH[DPLQHGpotential for 
optimisation of care in areas that may develop into adverse events (incorrect analgesia 
leading to unnecessary levels of pain, or incorrect VTE assessment leading to potential clot 
formation). However, a host of other literature supports the positive impact of pharmacist 
involvement in a variety of settings for enhanced patient satisfaction,7-8 improvement in 
clinical outcomes9-11 and reduction of errors.12-14 Results from this study suggest that 
identifying and prioritising high risk (red) patients at admission using the triage tool would 
have potential for improvements in clinical care, as these patients made up over three-
quarters of clinical problems that failed to be addressed. 
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For example, the incidence of VTE and pulmonary embolism has been shown to be 5-fold 
and 15-fold higher, respectively, in the postpartum period as compared to pregnancy 
alone.15 Approximately 20% of clinical interventions/missed opportunities (and 4% of patients 
in the study) had evidence of suboptimal LMWH dosing, duration or use. Assuming the 
aforementioned risk of VTE in postpartum women14 and obstetric capacity in the hospital 
over a year, this would have the potential to put approximately 260 postpartum women at 
risk and result in approximately 1 preventable VTE event each year. Triage of high risk 
patients to pharmacy services has potential to prevent such events.  
 
Our data collection stratified interventions and opportunities according to whether they were 
administrative, clinical or a combination of both. Administrative issues were captured based 
on their procedural potential to develop into errors. For instance, a lack of accurately 
recorded weight has been associated with a variety of errors, most commonly resulting in 
over- or under-dosage, and usually among high-risk medications.16 Lack of completeness 
and accuracy in charting is a known issue across many medical settings,17-19 but pharmacists 
can significantly improve these problems,20 and as a part of the multi-disciplinary team, have 
a professional obligation to optimise these practices whenever possible. The Safer Patients 
Initiative in the UK, published in 2011, identified medicines management as one of four key 
areas for improving reliability and safety in hospital care; among drivers promoting safe and 
effective processes, the use of standardised protocols, dose-guided algorithms and 
identification of high-risk areas were main components.21 Therefore, the administrative 
issues identified in the present analysis may reveal areas poised for quality improvement 
and safer obstetric care. 
 
The Standards for Maternity Care report, published by the Royal College of Obstetricians 
and Gynaecologists in 2008, notes the use of multi-disciplinary teams as an essential 
component of service delivery, particularly with regards to management of pre-existing 
medical conditions and intrapartum care.22 However, the contribution of pharmacists to this 
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goal, alongside obstetricians and other clinicians, has yet to be fully realised.23 Shared 
responsibility of medication-related issues across the multi-disciplinary team enhances 
patient care and lessens the potential for adverse events. At current time, pharmacists at the 
facility contribute to the development of practice guidelines and medical/pharmacy student 
teaching in addition to their clinical duties. Implementation of a triage tool would open up an 
untapped opportunity for pharmacy service involvement and input ± medication 
reconciliation. One study from the USA estimated that 85% of order errors among 
hospitalised patients originated from suboptimal medication histories.24 Guidance from the 
National Centre for Health and Clinical Excellence and the National Patient Safety Agency in 
the UK from 2007 states that policies should be in place to ensure responsibility for  an 
accurate medication history upon hospital admission.25 In 2012, the American Society of 
Health-System Pharmacists issued a statement on pharmacist involvement in medication 
reconciliation, recommending that the profession assume key roles in the development and 
execution of the process, while recognising that it remains a multi-disciplinary approach.25 
Implementation of the triage tool could be a good opportunity for efforts in medication 
reconciliation to be assisted by pharmacists, who are suited to contribute based on their 
training and expertise.27  
 
There are limitations associated with our work. As a retrospective quality improvement audit, 
the present study is restrained by its sample size and technique. However, birth statistics at 
the national level indicate the patient population included in this study to be well-matched 
with regards to mode of delivery, maternal age and gestation,28 demonstrating the external 
validity of our patient cohort. There is also limitation in the capture of pharmacist 
interventions through the use of retrospective data collection, as recommendations made by 
pharmacists on the ward may be verbal (and not documented in the chart), or pre-emptive to 
physician orders. Therefore, the issues captured by the current study likely represent only a 
sample of the full spectrum of pharmacist involvement in clinical care; however, full capture 
would not likely be possible under any research protocol.  
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WHAT IS NEW AND CONCLUSION: 
 
Evaluation of a triage tool for obstetric services demonstrated an effective means of 
targeting and prioritising higher risk patients for pharmacist review. Opportunities exist for 
several service improvements with said tool, including formalised medication reconciliation, 
better coordination within the multi-disciplinary team and prevention of adverse events 
through enhanced safety. Our future work will test clinical implementation of the triage tool 
on the ward on a longitudinal basis to investigate interdisciplinary acceptance of its use, as 
well as clinical outcomes. There is further potential in the future to expand pharmacist 
involvement into the late antenatal period through clinic visits, to pre-empt risk on admission 
and aid in service planning. 
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Figure 1: Obstetric service pharmacist triage tool 
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Table 1: Demographic and admission characteristics 
Characteristic Overall (n=175) Red (n=86) Green (n=89) 
Demographics   
Median age (IQR), years  29 (26-34) 29 (26-34) 29 (26-34.5) 
<18 years, n (%) 4 (2.3) 3 (3.5) 1 (1.1) 
18-29 years, n (%) 92 (52.9) 43 (50.6) 49 (55.1) 
30-35 years, n (%) 49 (28.2) 26 (30.6) 23 (25.8) 
\HDUVQ 29 (16.7) 13 (15.3) 16 (18.0) 
Median BMI (IQR), kg/m2 27.8 (23.9-31.5) 29.0 (25.0-35.7) 26.7 (22.9-29.8)  
Median gestation, 
weeks+days 
39+2 39+0 39+3 
Median gravida/parity G2 P1 G2 P1 G2 P1 
Admission   
Presentation    
Planned, n (%) 92 (52.6) 46 (53.5) 46 (51.7) 
Spontaneous, n (%) 83 (47.4) 40 (46.5) 43 (48.3) 
Median LOS (IQR), days 3 (2-4) 3 (2-4) 3 (2-4) 
Birth procedure    
SVD, n (%) 88 (50.6) 40 (47.6) 48 (53.9) 
EMCS, n (%) 35 (20.1) 21 (25.0) 14 (15.7) 
ELCS, n (%) 34 (19.5) 15 (17.9) 19 (21.4) 
Other, n (%) 16 (9.2) 8 (9.5) 8 (9.0) 

 p<0.05 for difference between red and green 
BMI: body mass index; ELCS: elective caesarean section; EMCS: emergency caesarean 
section; IQR: interquartile range; kg: kilograms; LOS: length of stay; m: metres; n: number; 
SD: standard deviation; SVD: spontaneous vaginal delivery 
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Table 2: Interventions by retrospective triage stratification 
Characteristic Overall (n=175) Red (n=86) Green (n=89) 
Pharmacist intervention 
during admission, n (%) 
86 (49.1) 45 (52.3) 41 (46.1) 
Administrative 52 (60.5) 25 (55.6) 27 (65.9) 
Clinical 18 (20.9) 9 (20.0) 9 (21.9) 
Administrative/clinical 16 (18.6) 11 (24.4) 5 (12.2) 
Professional screen at 
discharge, n (%) 
96 (54.9) 50 (58.1) 46 (51.7) 
Missed opportunities for 
intervention, n (%) 
117 (66.9) 65 (75.6) 52 (58.4)  
Administrative 78 (66.7) 36 (55.4) 42 (80.8)  
Clinical 22 (18.8) 17 (26.2) 5 (9.6) 
Administrative/clinical 17 (14.5) 12 (18.5) 5 (9.6) 

 p<0.05 for difference between red and green 
n: number 
 
 
 
